These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 4609331)
1. Mefruside: a preliminary report of its pharmacological properties and therapeutic efficacy in oedema and hypertension. Brogden RN; Speight TM; Avery GS Drugs; 1974; 7(6):419-25. PubMed ID: 4609331 [No Abstract] [Full Text] [Related]
2. A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension. Allen HB; Lee DA Curr Med Res Opin; 1973; 1(9):547-53. PubMed ID: 4779251 [No Abstract] [Full Text] [Related]
3. Side effects of antihypertensive drugs. Chrysant SG; Frohlich ED Am Fam Physician; 1974 Jan; 9(1):94-101. PubMed ID: 4149117 [No Abstract] [Full Text] [Related]
4. Clinical trial of mefruside, a new diuretic. Auld WH; Murdoch WR Br Med J; 1971 Dec; 4(5790):786-8. PubMed ID: 5135250 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of metolazone in patients with renal edema. Dargie HJ; Allison ME; Kennedy AC; Gray MJ Clin Nephrol; 1974; 2(4):157-60. PubMed ID: 4847130 [No Abstract] [Full Text] [Related]
7. [Pharmacology of N-(4'-chlore-3'-sulfameyl-benzelsulfenyl)-N-methyl-2-aminomethyl-2-methyl-tetrahydrefuran, a new diuretically active compound]. Meng K; Kroneberg G Arzneimittelforschung; 1967 Jun; 17(6):659-71. PubMed ID: 5632367 [No Abstract] [Full Text] [Related]
8. [Effect of mefruside on blood pressure and on potassium, magnesium and uric acid in the blood]. Broman J; Colling I; Dafgård T; Elander I; Helander S; Helldorff I; Jderberg E; Lidström P; Lindahl T; Luhr R; Modée H; Nandorf R; Nerell G; Sandefeldt A; Sjögren S; Thaning T; Treis F Lakartidningen; 1975 Mar; 72(12):1214-6. PubMed ID: 1134139 [No Abstract] [Full Text] [Related]
9. The role of renal dopamine and PGE2 in mediating the renal effects of the antihypertensive loop diuretic piretanide. Padfield PL; Hindawi RK; Corrie J; Reid MA; Chalmers D; Williams BC; Rademaker M Agents Actions Suppl; 1987; 22():197-204. PubMed ID: 3481209 [No Abstract] [Full Text] [Related]
10. Use of metolazone, a new diuretic, in patients with renal disease. Craswell PW; Ezzat E; Kopstein J; Varghese Z; Moorhead JF Nephron; 1974; 12(1):63-73. PubMed ID: 4838012 [No Abstract] [Full Text] [Related]
11. New drugs--No. 12. Metolazone (zaroxolyn). J Ir Med Assoc; 1972 Oct; 66(20):578. PubMed ID: 4667642 [No Abstract] [Full Text] [Related]
12. [Mechanism of the hypotensive effect of saluretic preparations in hypertensive diseases]. Liberman TIu Kardiologiia; 1971 May; 11(5):104-10. PubMed ID: 5126306 [No Abstract] [Full Text] [Related]
13. The sites of action of bumetanide in man. Bourke E; Asbury MJ; O'Sullivan S; Gatenby PB Eur J Pharmacol; 1973 Sep; 23(3):283-9. PubMed ID: 4583564 [No Abstract] [Full Text] [Related]
14. [Mefruside in clinical practice: activity and mechanism of action]. Perpignano G; Busilacchi M; Verzetti G Clin Ter; 1969 May; 49(4):337-63. PubMed ID: 5795021 [No Abstract] [Full Text] [Related]
15. A new diuretic that does not reduce renal handling of uric acid in rats, S-8666. Yonetani Y; Iwaki K; Ishii M; Harada H Jpn J Pharmacol; 1987 Apr; 43(4):399-405. PubMed ID: 3613286 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of metolazone in renal failure and the nephrotic syndrome. Bennett WM; Porter GA J Clin Pharmacol; 1973; 13(8):357-64. PubMed ID: 4579972 [No Abstract] [Full Text] [Related]
17. The effects of mefruside in the water diuretic and hydropenic dog: a comparison with chlorothiazide. Wilson CB; Kirkendall WM J Pharmacol Exp Ther; 1970 Jun; 173(2):422-9. PubMed ID: 5434024 [No Abstract] [Full Text] [Related]
18. Diuretics. II. Clinical considerations. Anderton JL; Kincaid-Smith P Drugs; 1971; 1(2):141-65. PubMed ID: 4939014 [No Abstract] [Full Text] [Related]